- Spot gold has just broken through the $4110.00/oz mark, now quoted at $4110.20/oz, up 1.08% on the day; COMEX gold futures main contract is now quoted at $4169.30/oz, up 1.76% on the day.
- US Stock Market Movement | Cloud Computing Service Provider NEBIUS (NBIS.US) Shares Surge Over 30%
- USD/JPY just broke through the 158.00 mark, last reported at 157.99, down 3.31% on the day.
- Spot gold has just surpassed the $4,090.00/oz mark, now quoted at $4,089.66/oz, up 0.58% on the day; main COMEX gold futures are quoted at $4,150.10/oz, up 1.30% on the day.
- AUD/JPY has just touched the 111.00 mark, currently reported at 111.00, down 2.28% on the day.
- Spot platinum has just broken through the $1,630.00/oz mark, now quoted at $1,629.90/oz, up 0.99% on the day; Nymex platinum futures main contract is currently quoted at $1,641.6/oz, up 2.45% on the day.
- AUD/USD rises 1.00% intraday, quoted at 0.7024
- The Thailand Futures Exchange (TFEX) has announced the temporary suspension of trading in USD/JPY futures.
- Shell CEO: The final investment decision for the Venezuela Dragon gas field is expected to be made in 2027.
- The yen surges across the board, with several yen currency pairs plunging over 100 points
- EUR/JPY has just broken through the 183.00 mark, now quoted at 182.99, down 2.31% on the day
- GBP/JPY just broke through the 213.00 mark, currently quoted at 212.96, down 2.47% on the day.
- USD/JPY just surpassed the 159.00 mark, latest quote at 158.99, down 2.71% intraday.
- The US dollar continues to decline against the Japanese yen, down 2.3% so far today, currently at 159.5 yen.
- U.S. Stocks Alert | Q2 revenue beats expectations but AI investment concerns persist, Meta (META.US) drops over 9%
- Spot gold has just surpassed the $4,100.00 per ounce mark, now quoted at $4,099.22 per ounce, up 0.81% for the day; main COMEX gold futures currently quoted at $4,160.30 per ounce, up 1.54% for the day.
- U.S. natural gas futures slightly retreat by about 1% as production hits a record high and inventories remain elevated; market awaits the weekly inventory report.
- GBP/JPY just hit the 214.00 mark, currently quoted at 214.00, down 2.00% on the day.
- The US Dollar Index falls below 100 points
- Kazuo Ueda: Monitoring the Impact of the Middle East Situation on the Japanese Economy
- The US Dollar Index posted a rare drop of over 0.86%, falling below 100 to 99.97. USD/JPY broke below 159.50, dropping more than -2.42%.
- Shell CEO: The volatility of the entire energy system has fundamentally intensified.
- According to Interfax, Russia has extended the ban on diesel and gasoline exports.
- The US dollar against the Japanese yen has fallen below the 160 mark, the first time since June 19.
- Fair Isaac Down Over 15%, on Pace for Largest Percent Decrease Since May 2025 -- Data Talk
- Chipotle Mexican Grill Up Over 11%, on Pace for Largest Percent Increase Since April 2023 -- Data Talk
- US To Sell $95 Bln In Reopened 6-Week Bills Tue
- Dow Jones Top Company Headlines at 11 AM ET: Amazon's Zoox Gets Clearance to Start Paid Robotaxi Rides | NYSE ...
- US To Sell $79 Bln In 6-Month Bills Mon
- Dow Jones 11:00 AM Averages
- US To Sell $52 Bln In 52-Week Bills Tue
- Correction to Amazon's Zoox Article -- WSJ
- EMCOR Up Over 18%, On Pace for Largest Percent Increase Since December 2008 -- Data Talk
- MarketAxess Up Over 29%, on Pace for Largest Percent Increase Since October 2008 -- Data Talk
- Cryptocurrencies Push Higher in Relief Rally -- Market Talk
- Apple Earnings: What to Expect Today -- WSJ
- Anglo American: Future Anglo Teck Leadership Roles Will Take Effect Upon Merger Completion
- Crocs 2Q Rev $1.18B >CROX
- Yum Brands 2Q Taco Bell Division Same-Store Sales Up 7% >YUM
- Huntington Ingalls 2Q Net Contract Awards $6.7B >HII
- Huntington Ingalls 2Q Net $208M >HII
- Tradeweb Markets 2Q Net $181.3M >TW
- Madrigal Pharmaceuticals 2Q Loss/Shr $1.99 >MDGL
- AMC Global Media 2Q Loss $21.9M >AMCX
- AMC Global Media 2Q Rev $547.5M >AMCX
- TriNet Group 2Q EPS $1.15 >TNET
- TriNet Group 2Q Adj EPS $1.55 >TNET
- Builders FirstSource 2Q Loss/Shr 4c >BLDR
- Builders FirstSource 2Q Sales $3.86B >BLDR
- Yum Brands 2Q KFC Division Same-Store Sales Up 2% >YUM
- OneWater Marine 3Q EPS 69c >ONEW
- Oil States 2Q EPS 10c >OIS
- Neogen 4Q Loss/Shr 5c >NEOG
- Crocs 2Q Net $204.9M >CROX
- Crocs 2Q Adj EPS $4.55 >CROX
- Yum Brands 2Q Pizza Hut Division Same-Store Sales Down 1% >YUM
- Neogen 4Q Loss $11.3M >NEOG
- Hilton Grand Vacations 2Q EPS 15c >HGV
- Hilton Grand Vacations 2Q Adj EPS 89c >HGV
- Hilton Grand Vacations 2Q Net $12M >HGV
- Hilton Grand Vacations 2Q Member Count 721,896 >HGV
- OneWater Marine 3Q Rev $530.7M >ONEW
- SunCoke Energy 2Q Net $13.1M >SXC
- SunCoke Energy 2Q EPS 15c >SXC
- Huntington Ingalls 2Q EPS $5.27 >HII
- Bristol Myers Squibb 2Q Growth Portfolio Revenue Rose 15% to $7.56B >BMY
- Affiliated Managers 2Q EPS $6.95 >AMG
- Affiliated Managers 2Q Economic EPS $8.29 >AMG
- Affiliated Managers 2Q Net $185.9M >AMG
- Steven Madden 2Q Adj EPS 44c >SHOO
- Bristol Myers Squibb 2Q EPS $1.62 >BMY
- Bristol Myers Squibb 2Q Rev $12.97B >BMY
- Bristol Myers Squibb 2Q Adj EPS $2.04 >BMY
- Bristol Myers Squibb Raises 2026 View To Adj EPS $6.75-Adj EPS $7 Vs Prior View $6.50-$6.35 >BMY
- Bristol Myers Squibb 2Q Gross Margin 71.3% >BMY
- Bristol Myers Squibb 2Q Adjusted Gross Margin 71.4% >BMY
- Bristol Myers Squibb: 2Q Growth Portfolio Revenue Increase Primarily Driven by Opdivo Qvantig, Reblozyl, Camzyos, Opdualag and Breyanzi >BMY
- Bristol Myers Squibb 2Q Legacy Portfolio Rev Fell 4% to $5.42B >BMY
- Bristol Myers Squibb 2Q Eliquis Revenue Rose 22% to $4.48B >BMY
- Phathom Pharmaceuticals 2Q Rev $74.3M >PHAT
- American Electric Power Reaffirms Annual Operating Earnings Growth Rate of 7%-9% Through 2030 >AEP
- Bristol Myers Squibb: 2026 Guidance Excludes Impact of Any Potential Future Strategic Acquisitions, Divestitures and Impact of Future Acquired IPRD Charges and Licensing Income Incurred After June 30 >BMY
- Bristol Myers Squibb Had Seen Total Worldwide Eliquis Revenue Increasing 10%-15% in 2026 >BMY
- Bristol Myers Squibb Now Sees Total Worldwide Eliquis Revenue Increasing 20%-25% in 2026 Vs Year-Ago >BMY
- Bristol Myers Squibb Had Seen 2026 Operating Expenses at About $16.3B >BMY
- Bristol Myers Squibb: Operating Expenses in 2026 Now Expected to Be About $16.5B Due to Increased Investment Behind Key Pipeline Programs and New Product Launches >BMY
- Bristol Myers Squibb Raises 2026 View To Rev $49B-$50B Vs Prior Guidance $46B-$47.5B >BMY
- Bristol Myers Squibb: As Result of Our Consistent Execution and Continued Momentum, Raising 2026 Full-Year Outlook >BMY
- Bristol Myers Squibb: Growth Portfolio Continues to Deliver, Represents Expanding Share of Overall Business >BMY
- Bristol Myers Squibb 2Q International Revenue Rose 6% to $3.98B >BMY
- Bristol Myers Squibb 2Q U.S. Revenue Rose 6% to $8.99B >BMY
- Bristol Myers Squibb: In Legacy Portfolio, Demand Increased for Eliquis in 2Q, Which Was More Than Offset by Expected Continued Generic Impacts Across Remainder of Portfolio >BMY
- A.O. Smith Boosts 2026 Share-Repurchase Target to $300M >AOS
- ADT Now Sees FY26 Revenue and Adj EPS Up 2%
- AO Smith 2Q Adj EPS $1.03 >AOS
- Trinity Industries 2Q Rev $485.1M >TRN
- Trinity Industries 2Q EPS $1.20 >TRN
- ADT 2Q Rev $1.31B >ADT
- Hyatt Hotels 2Q Adj EPS $1.12 >H
- Markets Ride a Roller Coaster of Fed Confusion -2-
